Treatment of attention deficit hyperactivity disorder in adults (Q34413877)

2 August 2017

1 reference

title

Treatment of attention deficit hyperactivity disorder in adults (English)

1 reference

attention deficit hyperactivity disorder

2 August 2017

0 references

1 reference

Brian Greenfield

1

1 reference

PubMed ID

15853481

2 August 2017

Lily Hechman

series ordinal

2

1 reference

2 August 2017

1 January 2005

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

2 August 2017

1 reference

2 August 2017

5

1 reference

2 August 2017

1

1 reference

2 August 2017

107-121

1 reference

Persistence of Attention-Deficit/Hyperactivity Disorder into adulthood: what have we learned from the prospective follow-up studies?

2 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Pharmacotherapy of adult attention deficit/hyperactivity disorder: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

How high a dose of stimulant medication in adult attention deficit hyperactivity disorder?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

A randomized, double-blind, crossover study of methylphenidate and lithium in adults with attention-deficit/hyperactivity disorder: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Meta-analysis of the efficacy of methylphenidate for treating adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Aggression, mania, and hypomania induction associated with atomoxetine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

An open trial of pargyline in the treatment of attention deficit disorder, residual type

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Venlafaxine versus stimulant therapy in patients with dual diagnosis ADD and depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Long-acting stimulants for the treatment of attention-deficit disorder in cocaine-dependent adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

Psychosocial treatments for adults with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

A cognitive remediation programme for adults with Attention Deficit Hyperactivity Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.5.1.107

21 January 2018

Identifiers

DOI

10.1586/14737175.5.1.107

1 reference

2 August 2017

1 reference

PubMed ID

15853481